After explant, is a lift the same decision as adding volume with fat?
Based on the livestream "Breast Explant Options: Lift vs Fat Transfer After Implants."
Source video: https://www.youtube.com/watch?v=MdJ9sBGoTag
Women ask this as if there were one correct add-on after implant removal. In this livestream, Dr. Robert Whitfield, MD, FACS, treated implant removal, skin and nipple position, and volume as three related questions that still have to be answered separately. The talk was education. He said he cannot determine a surgical plan from a livestream, a photograph, or a comment thread.
Three questions that get collapsed online
The first question is whether the implant should come out, and how the scar tissue around it is handled. In his practice he performs capsulectomy and tries to remove that tissue because debris from the shell can rest in the capsule. That is operative judgment in his hands. It is not a consumer product and it is not a law of nature for every surgeon.
The second question is the envelope. Where does the nipple sit relative to the fold. How much did the skin stretch around the device. Has there been pregnancy, weight change, or a prior lift. A lift, when it is discussed, is about reshaping that envelope and repositioning the nipple-areolar complex. It is not a volume operation.
The third question is volume after the device is gone. Fat transfer can add volume from the person's own tissue. It is not one to one with implant volume. It does not recreate an implant profile. It does not lift loose skin. It does not raise a nipple that sits substantially below the fold. Those limits are the point of the talk, not a footnote.
Explant alone remains an option
No one has to have a lift. No one has to have fat transfer. If the main goal is removal, explant can stand alone. If someone is not comfortable with extra scars, the lift is deferred. Volume coming out can still let tissues settle lower. That possibility belongs in the consent conversation before the operating room, not as a surprise after the fact.
He uses a practical teaching line for when a lift may be considered: the nipple sitting substantially below the fold. Substantially is a clinical word. An examination decides. A screenshot does not. Starting asymmetry is common. Breast augmentation does not make people symmetric, and explant cannot make them symmetric.
What fat transfer can and cannot do after implants
Fat harvest creates donor-site swelling, bruising, and discomfort. The lateral thigh is often the most sensitive area in his description. He uses nerve blocks and long-acting local anesthetic as part of that care. Over-grafting, he said, creates many later contour problems. Oil cysts are usually straightforward to follow. Anything that looks like fat necrosis can be seen on ultrasound or mammogram, or both. Tell the imaging team that fat transfer was done. Additional views may be needed if a finding is unclear.
He does not place fat in the old implant pocket. Fat belongs in the fatty plane under the skin. Same-day combination of explant, lift, and fat transfer is gated. He wants people prepared first, including a detailed look at exposures and gut findings as information, not as a livestream diagnosis. If another surgeon recommends staging the volume work, he said that can be appropriate when the person understands the trade.
Optional tightening at the donor site, not a required bundle
Skin laxity increases with age. For fat-removal donor areas, he offers BodyTite for deeper tightening and Morpheus8 for more superficial texture work as optional adjuncts after individualized analysis and consent. They are not mandatory, they are not a breast lift, and they are not a substitute for choosing explant alone when that is the right plan. Office technologies he named in other contexts, including Sofwave, EvolveX, and Evoke, are separate from this donor-site discussion.
Pocket location changes the work, not the slogan
When an implant sits in front of the muscle, capsule access is more direct. When it sits behind the muscle, the muscle is reflected like a fan, capsule along the rib cage and the underside of the muscle is addressed, and the muscle is repaired, especially toward the inner lower breast. That is why pocket history belongs in the chart. It is not a reason to promise one specimen pattern in every case.
Why photographs and comments cannot plan the operation
A photo can start a conversation. It cannot show tissue thickness, how skin will recoil after the device is gone, or most of the scar tissue around an implant. Low body weight does not, by itself, answer whether enough donor fat exists. He said he uses a DEXA scan together with examination for lower body-weight patients considering fat transfer, rather than BMI alone. That still requires an in-person evaluation. A livestream cannot assign you a lift, a fat-transfer volume, or a scar pattern.
Capsule findings and what molecular tests do not prove
He described capsule removal in part because debris from the implant shell can rest in that tissue, and because published molecular findings in submitted specimens showed bacterial DNA in a minority of those samples. 203 of 694 submitted capsule and tissue specimens (about 29 percent) had positive targeted 16S findings (PMID 39338504). That is a rate among submitted specimens, not among all people with implants. Detection of bacterial DNA fragments associated with biofilm does not establish that organisms were alive, that a clinical infection is present, or that any one person needs a specific treatment. The livestream used shorter language. Public education should keep the specimen denominator and the detection-versus-infection limit.
What this livestream actually taught
The talk was built around a planning problem, not a product. After implant removal, people often collapse three different questions into one screenshot. He separated them. First, should the implant come out, and how is the capsule handled in that operation. Second, what is happening with the skin envelope and the nipple position relative to the fold. Third, if volume is desired after the device is gone, what can fat transfer realistically add. Those questions are related. They are not the same operation, the same scar, or the same recovery.
He was explicit that explant alone is always an option. A lift is considered when the nipple sits substantially below the fold, not because an implant receipt listed a certain size. Fat is used for volume. Fat cannot lift loose skin. Fat cannot raise a low nipple. Fat cannot recreate the projection profile of an implant. Density is different. Placement is different. He does not put fat into the old implant pocket. In his description, fat belongs in the fatty plane beneath the skin, above the breast tissue.
Results after explant vary. Implant size, how long the device has been in place, skin quality, tissue thickness, and starting nipple position all change what the breast looks like once the volume of the device is gone. That is why a photograph is a conversation starter and not a surgical plan. Tissue thickness, how the skin will recoil, and most of the scar tissue around a device are not visible in a still image.
When someone wants volume after removal, he described fat harvest from typical donor areas, with the lateral thigh often the most sensitive. Swelling, bruising, and discomfort at donor sites are expected risks. Over-grafting, in his view, creates many of the contour problems people worry about later. Oil cysts and areas that look like fat necrosis can show up on ultrasound or mammogram. The imaging team needs to know that fat transfer was performed. Fat transfer has been used in reconstructive settings for many years. Additional imaging may still be needed if a finding is unclear. That is not the same as a claim that screening never changes.
For donor-site contour, he offers deeper tightening with BodyTite and more superficial treatment with Morpheus8 as optional adjuncts after individualized analysis and consent. They are not a required bundle and they are not a facelift of the breast. A lift, when it is chosen, reshapes the envelope and repositions the nipple-areolar complex. Combining removal, a lift, and fat transfer in one anesthetic is one option after preparation. If another surgeon recommends staging, he said that can be a reasonable plan when the person understands it.
Pocket location changes the work of capsule removal. When the implant sits in front of the muscle, access is more direct. When it sits behind the muscle, the muscle is reflected and the capsule along the rib cage and the underside of the muscle has to be addressed, then the muscle is repaired. That is anatomy teaching, not a promise that every capsule comes out as one unbroken specimen in every body. Capsule management is individualized.
He described trying to remove capsule because debris from an implant shell can rest in that tissue, and because published molecular work on submitted specimens found bacterial DNA in a minority of those samples. Keep the published limit. 203 of 694 submitted capsule and tissue specimens (about 29 percent) had positive targeted 16S findings (PMID 39338504). That is a rate among submitted specimens, not among all people with implants. Detection of bacterial DNA fragments associated with biofilm does not establish that organisms were alive, that a clinical infection is present, or that any one person needs a specific treatment. A food-poisoning story from the livestream was a single unusual case, not a typical explant presentation, and it is not used here as a population claim.
Preparation in his practice is a long horizon. History, implant surface, pocket, prior operations, pregnancies, weight change, medications, habits, and existing imaging all belong in the chart before anyone is asleep. For lower body-weight patients considering fat transfer, he said he uses a DEXA scan together with examination rather than BMI alone. That is his planning tool. It is not a public screening test and it does not assign candidacy from a comment. In-office tools he named, including hyperbaric oxygen, the Human Regenerator, Flowpresso, red light, and NanoVi, were framed as adjuncts some patients in his Austin office may use. They are not a universal recovery protocol and they are not a substitute for the operation you actually need, or do not need.
The SHARP framework
Preparation is not an extra. In this talk, Dr. Whitfield described how history, implant type, pocket location, prior operations, pregnancies, weight change, medications, habits, and imaging all belong in the plan before anyone is in an operating room. He also described recovery as individualized stacking of nutrition, supplementation when appropriate, sleep, walking, and in-office supportive therapies rather than one protocol for every procedure.
The SHARP approach, Strategic Holistic Accelerated Recovery Program, is the practice framework used to organize that work: evaluate the whole picture, prepare the person, operate with a safety-first plan, then support recovery. It is not a promise that swelling, sensation, donor-site contour, or scars will follow one timeline.
Learn more about SHARP: https://www.drrobertwhitfield.com/sharp
SHARP book: https://www.drrobssolutions.com/products/sharp-by-dr-robert-whitfield
Questions people actually ask
Do I have to have a lift after explant? No. Explant can stand alone.
Does fat transfer lift the breast or raise a low nipple? No. Fat adds volume. A lift reshapes the envelope.
Can fat recreate the look of an implant? No. Density and projection are different.
Is combination surgery required? No. Staging can be appropriate. Combination is one option after preparation.
Can a photo tell me which option I need? No. History, examination, and sometimes imaging complete the picture.
Do BodyTite and Morpheus8 have to be added to fat harvest? No. They are optional adjuncts after individualized analysis.
Do molecular findings in a published specimen series diagnose my capsules? No. Detection is not infection and a series is not your operation.
What this livestream was, and was not
It was a teaching session on three planning questions after implants. It was not a remote surgical consult. He said everyone considering a procedure like this needs to be seen. That limit is part of the medicine, not a disclaimer tacked on at the end.
Where to go next
If you want individualized information about explant, lift, and fat-transfer planning, schedule a Discovery Call with the Austin team. Bring implant history, pocket location, prior operations, pregnancies, imaging, and the questions you are nervous to ask. A livestream cannot assign you a plan.
Discovery Call: https://discovery.drrobertwhitfield.com/form
Explant resource: https://www.drrobertwhitfield.com/explant
Breast implant illness symptoms hub: https://www.drrobertwhitfield.com/breast-implant-illness-symptoms
Store: https://www.drrobssolutions.com
SHARP book: https://www.drrobssolutions.com/products/sharp-by-dr-robert-whitfield
Disclaimer
This material is educational and is not medical advice, a diagnosis, or a treatment plan. It does not establish a physician-patient relationship. Individual findings, imaging, and in-person examination determine what is appropriate. Consult your own licensed clinician before making medical decisions.
203 of 694 submitted capsule and tissue specimens (about 29 percent) had positive targeted 16S findings (PMID 39338504). That is a rate among submitted specimens, not among all people with implants. Detection of bacterial DNA fragments associated with biofilm does not establish that organisms were alive, that a clinical infection is present, or that any one person needs a specific treatment.